Sabine Vukelich

Sabine is regulatory leader with over 20 years of global regulatory experience in various therapeutic areas across all phases of development, including experience with small molecules as well as biologics. Sabine was most recently Vice President Regulatory Affairs at Retrotope, Inc., a clinical-stage biopharmaceutical company focused on the development of first-in-class therapies for degenerative diseases. Previously, Sabine served as Vice President Regulatory Affairs & QA at Protagonist Therapeutics. Prior to Protagonist, Sabine held various positions at Global Blood Therapeutics, XOMA, Novartis Pharmaceuticals Corporation, Chiron Corporation, Roche Global Development, and Hoffmann-La Roche AG, Germany.

Sabine is a trained pharmacist with a federal degree from Albert-Ludwigs-University Freiburg, Germany. She holds a PhD from the University of Hamburg, Germany, Faculty of Chemistry.